(S)-4-Isopropyl-5,5-diphenyloxazolidin-2-one has been synthesized for the first time by the enantiospecific oxidative carbonylation of commercially available (S)-2-amino-3-methyl-1,1-diphenylbutan-1-ol. The cyclocarbonylation reaction was carried out at 100 °C in 1,2-dimethoxyethane (DME) as the solvent for 15 h, under 20 atm of a 4:1 mixture of CO–air and in the presence of the catalytic system PdI2/KI (substrate:KI:PdI2 molar ratio = 100:10:1), to give the oxazolidinone derivative in 81% isolated yield.
The iodolactonization of 3‐alkynylthiophene‐2‐carboxylic acids and 3‐alkynylpicolinic acids has been investigated. Using I2 as the iodine source and NaHCO3 as the base in MeCN, the process took place smoothly to afford thienopyranones and pyranopyridinones, respectively, from 6‐endo‐dig cyclization. The method also worked nicely for the transformation of 2‐(phenylethynyl)thiophene‐3‐carboxylic acid and 3‐(phenylethynyl)isonicotinic acid into 7‐iodo‐6‐phenyl‐4H‐thieno[3,2‐c]pyran‐4‐one and 4‐iodo‐3‐phenyl‐1H‐pyrano[4,3‐c]pyridin‐1‐one, respectively. Although with some 3‐alkynylpicolinic acids the process led to a mixture of the 6‐endo‐dig and 5‐exo‐dig products, it could be still made selective toward the pyranopyridinone compound working in 1‐ethyl‐3‐methylimidazolium ethyl sulfate as the solvent. On the other hand, the exclusive formation of the 5‐exo‐dig product was observed in N‐ethyl‐N‐methylmorpholinium dicyanamide starting from 3‐(3,3‐dimethylbut‐1‐yn‐1‐yl)picolinic acid. Some representative iodinated thienopyridinone products were successfully used as substrates for Pd‐catalyzed Suzuki and Sonogashira reactions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.